D2E7-Early AS
NCT00235105
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
UNKNOWN
Status
46
Enrollment
OTHER
Sponsor class
Conditions
Ankylosing Spondylitis
Interventions
DRUG:
Adalimumab 40 mg sc every other week
Sponsor
Charite University, Berlin, Germany
Collaborators
[object Object]